QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, October 1, 2003, 23(26):8836-8843

This Article Full Text Full Text (PDF) Supplemental Tables Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (32) Citing Articles via Google Scholar Google Scholar Articles by González-Maeso, J. Articles by Sealfon, S. C. Search for Related Content PubMed PubMed Citation Articles by González-Maeso, J. Articles by Sealfon, S. C.

 Previous Article  |  Next Article 

Cellular/Molecular
Transcriptome Fingerprints Distinguish Hallucinogenic and Nonhallucinogenic 5-Hydroxytryptamine 2A Receptor Agonist Effects in Mouse Somatosensory Cortex

Javier González-Maeso,¹ Tony Yuen,¹ Barbara J. Ebersole,¹ Elisa Wurmbach,¹ Alena Lira,⁴ Mingming Zhou,⁴ Noelia Weisstaub,⁴ Rene Hen,⁵ Jay A. Gingrich,⁴ and Stuart C. Sealfon^1,2,3

¹Department of Neurology, ²Fishberg Center for Neurobiology, and ³Department of Pharmacology and Biological Chemistry, Mount Sinai School of Medicine, New York, New York 10029, and ⁴Department of Psychiatry and ⁵Center for Neurobiology and Behavior, Columbia University, New York, New York 10032

Most neuropharmacological agents and many drugs of abuse modulate the activity of heptahelical G-protein-coupled receptors. Although the effects of these ligands result from changes in cellular signaling, their neurobehavioral activity may not correlate with results of in vitro signal transduction assays. 5-Hydroxytryptamine 2A receptor (5-HT2AR) partial agonists that have similar pharmacological profiles differ in the behavioral responses they elicit. In vitro studies suggest that different agonists acting at the same receptor may establish distinct patterns of signal transduction. Testing this hypothesis in the brain requires a global signal transduction assay that is applicable in vivo. To distinguish the cellular effects of the different 5-HT2AR agonists, we developed an assay for global signal transduction on the basis of high throughput quantification of rapidly modulated transcripts. Study of the responses to agonists in human embryonic kidney 293 cells stably expressing 5-HT2ARs demonstrated that each agonist elicits a distinct transcriptome fingerprint. We therefore studied behavioral and cortical signal transduction responses in wild-type and 5-HT2AR null-mutant mice. The hallucinogenic chemicals (±)-2,5-dimethoxy-4-iodoamphetamine (DOI) and lysergic acid diethylamide (LSD) stimulated a head-twitch behavioral response that was not observed with the nonhallucinogenic lisuride hydrogen maleate (LHM) and was absent in receptor null-mutant mice. We also found that DOI, LSD, and LHM each induced distinct transcriptome fingerprints in somatosensory cortex that were absent in 5-HT2AR null-mutants. Moreover, DOI and LSD showed similarities in the transcriptome fingerprints obtained that were not observed with the behaviorally inactive drug LHM. Our results demonstrate that chemicals acting at the 5-HT2AR induce specific cellular response patterns in vivo that are reflected in unique changes in the somatosensory cortex transcriptome.

Key words: 5-HT_2A receptor; hallucinogen; LSD; serotonin; signal transduction; somatosensory cortex

---

Received March 13, 2003; revised August 1, 2003; accepted August 1, 2003.

This article has been cited by other articles:

				G. Molinaro, A. Traficante, B. Riozzi, L. Di Menna, M. Curto, S. Pallottino, F. Nicoletti, V. Bruno, and G. Battaglia Activation of mGlu2/3 Metabotropic Glutamate Receptors Negatively Regulates the Stimulation of Inositol Phospholipid Hydrolysis Mediated by 5-Hydroxytryptamine2A Serotonin Receptors in the Frontal Cortex of Living Mice Mol. Pharmacol., August 1, 2009; 76(2): 379 - 387. [Abstract] [Full Text] [PDF]

				A. I. Abbas, P. N. Yadav, W.-D. Yao, M. I. Arbuckle, S. G. N. Grant, M. G. Caron, and B. L. Roth PSD-95 Is Essential for Hallucinogen and Atypical Antipsychotic Drug Actions at Serotonin Receptors J. Neurosci., June 3, 2009; 29(22): 7124 - 7136. [Abstract] [Full Text] [PDF]

				M. M. Escribese, T. Kraus, E. Rhee, A. Fernandez-Sesma, C. B. Lopez, and T. M. Moran Estrogen inhibits dendritic cell maturation to RNA viruses Blood, December 1, 2008; 112(12): 4574 - 4584. [Abstract] [Full Text] [PDF]

				L. R. Gardell, K. E. Vanover, L. Pounds, R. W. Johnson, R. Barido, G. T. Anderson, I. Veinbergs, A. Dyssegaard, P. Brunmark, A. Tabatabaei, et al. ACP-103, a 5-Hydroxytryptamine 2A Receptor Inverse Agonist, Improves the Antipsychotic Efficacy and Side-Effect Profile of Haloperidol and Risperidone in Experimental Models J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 862 - 870. [Abstract] [Full Text] [PDF]

				J. D. Urban, W. P. Clarke, M. von Zastrow, D. E. Nichols, B. Kobilka, H. Weinstein, J. A. Javitch, B. L. Roth, A. Christopoulos, P. M. Sexton, et al. Functional Selectivity and Classical Concepts of Quantitative Pharmacology J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 1 - 13. [Abstract] [Full Text] [PDF]

				A. Fernandez-Sesma, S. Marukian, B. J. Ebersole, D. Kaminski, M.-S. Park, T. Yuen, S. C. Sealfon, A. Garcia-Sastre, and T. M. Moran Influenza Virus Evades Innate and Adaptive Immunity via the NS1 Protein. J. Virol., July 1, 2006; 80(13): 6295 - 6304. [Abstract] [Full Text] [PDF]

				M. L. Shaw, W. B. Cardenas, D. Zamarin, P. Palese, and C. F. Basler Nuclear Localization of the Nipah Virus W Protein Allows for Inhibition of both Virus- and Toll-Like Receptor 3-Triggered Signaling Pathways J. Virol., May 15, 2005; 79(10): 6078 - 6088. [Abstract] [Full Text] [PDF]

				J. Zhang, A. Moseley, A. G. Jegga, A. Gupta, D. P. Witte, M. Sartor, M. Medvedovic, S. S. Williams, C. Ley-Ebert, L. M. Coolen, et al. Neural system-enriched gene expression: relationship to biological pathways and neurological diseases Physiol Genomics, July 8, 2004; 18(2): 167 - 183. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help